← К результатам

Clin Genet · 2020

Applications of CRISPR-Cas9 in gynecological cancer research.

Clinical genetics, 97(6): 827-834 PMID 32040210 DOI 10.1111/cge.13717

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

Gynecological cancers pose a significant threat to women's health worldwide, with cervical cancer, ovarian cancer, and endometrial cancer having high incidences. Current gynecological cancer treatment methods mainly include surgery, chemotherapy, radiotherapy, and chemoradiotherapy. The CRISPR-Cas9 gene editing technology as a new therapeutic method has shown tremendous effect in the treatment of other cancers, promoting research on its potential therapeutic effect in gynecological cancer. In this article, we reviewed the current research status of CRISPR-Cas9 technology in gynecological cancer, focusing on the importance of studying the mechanism of CRISPR-Cas9 in gynecological cancer treatment, thereby laying a foundation for further research on its clinical application.

Цитирование